Synapmed Global Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 58.12%
- Profit Growth 1638.70%
- Ebitda 1182.19%
- Net Worth 851.13%
- Total Assets 230.06%
About Synapmed Global
Synapmed Global Private Limited (SGPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 February 2020 (Four years and 11 months 20 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tarun Prashanth, Jayalakshmi Maduranath, and Krishnankutty Ravisankar serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100KA2020PTC132944
-
Company No.
132944
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Feb 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Synapmed Global?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarun Prashanth
|
Director | 03-Nov-2021 | Current |
Jayalakshmi Maduranath
|
Additional Director | Current | |
|
Krishnankutty Ravisankar
|
Director | 01-Aug-2023 | Current |
Financial Performance of Synapmed Global.
Synapmed Global Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 58.12% increase. The company also saw a substantial improvement in profitability, with a 1638.7% increase in profit. The company's net worth Soared by an impressive increase of 851.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synapmed Global?
Unlock access to Synapmed Global's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synapmed Global?
Synapmed Global has a workforce of 54 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synapmed Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synapmed Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
